KMT2D c.2371C>G ;(p.Q791E)

Variant ID: 12-49445095-G-C

NM_003482.3(KMT2D):c.2371C>G;(p.Q791E)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Assessing variants of uncertain significance implicated in hearing loss using a comprehensive deafness proteome.

Human Genetics
Tollefson, Mallory R MR; Gogal, Rose A RA; Weaver, A Monique AM; Schaefer, Amanda M AM; Marini, Robert J RJ; Azaiez, Hela H; Kolbe, Diana L DL; Wang, Donghong D; Weaver, Amy E AE; Casavant, Thomas L TL; Braun, Terry A TA; Smith, Richard J H RJH; Schnieders, Michael J MJ
Publication Date: 2023-04-22

Variant appearance in text: KMT2D: 2371C>G; Gln791Glu
PubMed Link: 37086329
Variant Present in the following documents:
  • 439_2023_2559_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial.

Cancers
Lee, Che-Jui CJ; Modave, Elodie E; Boeckx, Bram B; Stacchiotti, Silvia S; Rutkowski, Piotr P; Blay, Jean-Yves JY; Debiec-Rychter, Maria M; Sciot, Raf R; Lambrechts, Diether D; Wozniak, Agnieszka A; Schöffski, Patrick P
Publication Date: 2021-12-01

Variant appearance in text: KMT2D: Q791E
PubMed Link: 34885165
Variant Present in the following documents:
  • Main text
  • cancers-13-06057.pdf
View BVdb publication page



Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial.

Cancers
Lee, Che-Jui CJ; Modave, Elodie E; Boeckx, Bram B; Stacchiotti, Silvia S; Rutkowski, Piotr P; Blay, Jean-Yves JY; Debiec-Rychter, Maria M; Sciot, Raf R; Lambrechts, Diether D; Wozniak, Agnieszka A; Schöffski, Patrick P
Publication Date: 2021-12-01

Variant appearance in text: KMT2D: Q791E
PubMed Link: 34885165
Variant Present in the following documents:
  • Main text
  • cancers-13-06057.pdf
View BVdb publication page